Moderna Announces Promising Results for Combination Influenza and Covid-19 Vaccine in Phase 1/2 Trial
Dubai, United Arab Emirates (CNN) – Moderna announced on Wednesday that in Phase 1/2 of its clinical trial, its combination vaccine appeared to elicit “strong” immune responses against both influenza and “Covid-19,” and it was found that it security. The experimental vaccine, called mRNA-1083, was developed to provide some protection against both influenza and Covid-19 … Read more